Data / Form D filings / Xanadu Bio, Inc.
Xanadu Bio, Inc.: Form D filings
Xanadu Bio, Inc., a biotechnology company in Gladwyne, PA, filed 2 Form D notices with the SEC between 2022 and 2025. The latest, on August 27, 2025, reports $11 million sold of a $11 million offering to 4 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 980 IDLEWILD ROAD, Gladwyne, PA, 19035
- Phone
- (610) 937-6000
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2021
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1946059
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Aug 27, 2025 | New notice | $10,999,994 | $10,999,994 | 4 | Aug 13, 2025 | sec.gov | |
| Dec 27, 2022 | New notice | $30,000,000 | $11,999,986 | $18,000,014 | 8 | Aug 16, 2022 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Taylor Feehley | Executive Officer | |
| Mark Saltzman | Director | |
| Todd Wider | Director, Executive Officer, Promoter | |
| Bruce Turner | Director, Executive Officer, Promoter |
Other biotechnology companies in Pennsylvania that filed recently
- BioLattice Ophthalmics, Inc, $1.8 million · Oct 28, 2026
- Myris Therapeutics, Inc. $500,000 · Oct 14, 2026
- Praeventix, Inc. $5.6 million · Sep 10, 2026
- Plowshare Therapies LLC $6.7 million · Aug 31, 2026
- Noveome Biotherapeutics, Inc. $6.8 million · Aug 27, 2026
- AlloTRx Bio Inc. $500,000 · Aug 24, 2026
Every Form D from the week of Aug 25, 2025 · All recent filings in Pennsylvania · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Xanadu Bio, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.